Cargando…
Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14(+) Monocytes
BACKGROUND: Surfactant replacement therapy is the standard of care for the prevention and treatment of neonatal respiratory distress syndrome. New generation synthetic surfactants represent a promising alternative to animal-derived surfactants. CHF5633, a new generation reconstituted synthetic surfa...
Autores principales: | Glaser, Kirsten, Fehrholz, Markus, Curstedt, Tore, Kunzmann, Steffen, Speer, Christian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720484/ https://www.ncbi.nlm.nih.gov/pubmed/26790130 http://dx.doi.org/10.1371/journal.pone.0146898 |
Ejemplares similares
-
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4(+) Lymphocytes
por: Fehrholz, Markus, et al.
Publicado: (2016) -
Impact of synthetic surfactant CHF5633 with SP‐B and SP‐C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome
por: Mikolka, Pavol, et al.
Publicado: (2021) -
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
por: Sweet, David G, et al.
Publicado: (2017) -
Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA
por: Fehrholz, Markus, et al.
Publicado: (2012) -
Expression of surfactant protein B is dependent on cell density in H441 lung epithelial cells
por: Fehrholz, Markus, et al.
Publicado: (2017)